![]() The efficacy of a CK2 inhibitor, CX-4945, and paclitaxel was evaluated in GC cell lines and a xenograft model. Experimental designĬK2 expression was evaluated in 59 advanced GC patients treated with paclitaxel as the second-line therapy. We investigated the mechanistic basis for the association between CK2 activation and paclitaxel resistance in a gastric cancer (GC). ![]() Casein kinase (CK) 2 activation has been implicated in the proliferation of various tumor types and resistance to chemotherapy. ![]()
0 Comments
Leave a Reply. |
Details
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |